Nevertheless, despite the use of G-CSF in mobilization of HSPCs to the PB and after multiple days of apheresis, 40–50% of patients with MM remain unable to collect optimal numbers of HSPCs for ASCT11,12. This evidence concerns the gene CSF3 and Miyoshi myopathy.